Search research articles
Contact Us
Filters
Showing results (111-120 of 227) with videos related to
Page
of 23
Sort By:
Journal of Medical Primatology
|
September 1, 1993
Chimpanzees in AIDS research: a biomedical and bioethical perspective
R van Akker, M Balls, J W Eichberg, et al.
The Journal of General Virology
|
November 20, 2009
Characterization of novel polyomaviruses from Bornean and Sumatran orang-utans
Marlous J Groenewoud, Zahra Fagrouch, Sabine van Gessel, et al.
Journal of Virology
|
May 16, 2008
Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities
Sam J Wilson, Benjamin L J Webb, Charlotte Maplanka, et al.
Virology
|
June 6, 1998
Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection
R Wagner, V J Teeuwsen, L Deml, et al.
The Journal of General Virology
|
April 1, 1995
Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination
P ten Haaft, M Cornelissen, J Goudsmit, et al.
Frontiers in Immunology
|
July 22, 2021
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
Youssif M Ali, Matteo Ferrari, Nicholas J Lynch, et al.
Vaccine
|
November 19, 1997
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen
D Davis, B Morein, L Akerblom, et al.
Journal of Virology
|
January 22, 2000
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques
B Rosenwirth, P ten Haaft, W M Bogers, et al.
Vaccine
|
September 1, 1995
Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories
E G Hulskotte, G F Rimmelzwaan, J Boes, et al.
Journal of Virology
|
February 7, 2001
Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy
P Mooij, W M Bogers, H Oostermeijer, et al.
Page
of 23
Search research articles
Search
Showing results (111-120 of 227) with videos related to
Sort By:
Page
of 23
Journal of Medical Primatology
|
September 1, 1993
Chimpanzees in AIDS research: a biomedical and bioethical perspective
R van Akker, M Balls, J W Eichberg, et al.
The Journal of General Virology
|
November 20, 2009
Characterization of novel polyomaviruses from Bornean and Sumatran orang-utans
Marlous J Groenewoud, Zahra Fagrouch, Sabine van Gessel, et al.
Journal of Virology
|
May 16, 2008
Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities
Sam J Wilson, Benjamin L J Webb, Charlotte Maplanka, et al.
Virology
|
June 6, 1998
Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection
R Wagner, V J Teeuwsen, L Deml, et al.
The Journal of General Virology
|
April 1, 1995
Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination
P ten Haaft, M Cornelissen, J Goudsmit, et al.
Frontiers in Immunology
|
July 22, 2021
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
Youssif M Ali, Matteo Ferrari, Nicholas J Lynch, et al.
Vaccine
|
November 19, 1997
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen
D Davis, B Morein, L Akerblom, et al.
Journal of Virology
|
January 22, 2000
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques
B Rosenwirth, P ten Haaft, W M Bogers, et al.
Vaccine
|
September 1, 1995
Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories
E G Hulskotte, G F Rimmelzwaan, J Boes, et al.
Journal of Virology
|
February 7, 2001
Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy
P Mooij, W M Bogers, H Oostermeijer, et al.
Page
of 23